By Özge ÖzkayaClinical Trial Tested Safety of Potential New Drug to Manage Endometriosis
By Özge Özkaya
The non-peptide gonadotropin-releasing hormone antagonist SHR7280 has favorable safety, pharmacokinetics, and pharmacodynamics in 3 different doses, according to the results of a phase 1 clinical trial published in the scientific journal Clinical Pharmacokinetics. “The results of this study provide evidence to…
Key Points Lay Summary